{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:21:43Z","timestamp":1790691703043,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00198-023-06708-8","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T05:02:32Z","timestamp":1677733352000},"page":"1075-1084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness\u2013adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1826-5958","authenticated-orcid":false,"given":"Didier","family":"Hans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-0778","authenticated-orcid":false,"given":"Michele","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6338-2948","authenticated-orcid":false,"given":"Enisa","family":"Shevroja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McClung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"6708_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","volume":"34","author":"SC Schuit","year":"2004","unstructured":"Schuit SC, van der Klift M, Weel AE et al (2004) Fracture incidence and association with bone mineral density in elderly. Bone 34:195\u2013202","journal-title":"Bone"},{"key":"6708_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","volume":"18","author":"BC Silva","year":"2015","unstructured":"Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD Official Positions Part 2: trabecular bone score. J Clin Densitom 18:309\u2013330","journal-title":"J Clin Densitom"},{"key":"6708_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11914-005-0005-y","volume":"3","author":"MR McClung","year":"2005","unstructured":"McClung MR (2005) The relationship between bone mineral density and fracture risk. Curr Osteoporos Rep 3:57\u201363","journal-title":"Curr Osteoporos Rep"},{"key":"6708_CR4","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","volume":"164","author":"ES Siris","year":"2004","unstructured":"Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164:1108\u20131112","journal-title":"Arch Intern Med"},{"key":"6708_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1503\/cmaj.070234","volume":"177","author":"A Cranney","year":"2007","unstructured":"Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007) Low bone mineral density and fracture burden in postmenopausal women. CMAJ 177:575\u2013580","journal-title":"CMAJ"},{"key":"6708_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jocd.2011.05.005","volume":"14","author":"D Hans","year":"2011","unstructured":"Hans D, Barthe N, Boutrop S et al (2011) Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom 14:302\u2013312","journal-title":"J Clin Densitom"},{"key":"6708_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N et al (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518\u2013530","journal-title":"J Bone Miner Res"},{"key":"6708_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bone.2015.06.007","volume":"79","author":"C Muschitz","year":"2015","unstructured":"Muschitz C, Kocijan R, Haschka J et al (2015) TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures. Bone 79:259\u2013266","journal-title":"Bone"},{"key":"6708_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00223-009-9322-y","volume":"86","author":"R Winzenrieth","year":"2010","unstructured":"Winzenrieth R, Dufour R, Pothuaud L, Hans D (2010) A retrospective case-control study assessing the role of trabecular bone score in postmenopausal Caucasian women with osteopenia: analyzing the odds of vertebral fracture. Calcif Tissue Int 86:104\u2013109","journal-title":"Calcif Tissue Int"},{"key":"6708_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00223-015-9980-x","volume":"96","author":"EV McCloskey","year":"2015","unstructured":"McCloskey EV, Od\u00e9n A, Harvey NC et al (2015) Adjusting fracture probability by trabecular bone score. Calcif Tissue Int 96:500\u2013509","journal-title":"Calcif Tissue Int"},{"key":"6708_CR11","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00198-014-2761-y","volume":"25","author":"WD Leslie","year":"2014","unstructured":"Leslie WD, Johansson H, Kanis JA, Lamy O, Oden A, McCloskey EV, Hans D (2014) Lumbar spine texture enhances 10-year fracture probability assessment. Osteoporos Int 25:2271\u20132277","journal-title":"Osteoporos Int"},{"key":"6708_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jbmr.2734","volume":"31","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Od\u00e9n A, Harvey NC, Leslie WD, Hans D et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 31:940\u2013948","journal-title":"J Bone Miner Res"},{"key":"6708_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11914-017-0410-z","volume":"15","author":"D Hans","year":"2017","unstructured":"Hans D, \u0160te\u0148ov\u00e1 E, Lamy O (2017) The trabecular bone score (TBS) complements DXA and the FRAX as a fracture risk assessment tool in routine clinical practice. Curr Osteoporos Rep 15:521\u2013531","journal-title":"Curr Osteoporos Rep"},{"key":"6708_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jocd.2017.06.019","volume":"20","author":"E Shevroja","year":"2017","unstructured":"Shevroja E, Lamy O, Kohlmeier L, Koromani F, Rivadeneira F, Hans D (2017) Use of trabecular bone score (TBS) as a complementary approach to dual-energy X-ray absorptiometry (DXA) for fracture risk assessment in clinical practice. J Clin Densitom 20:334\u2013345","journal-title":"J Clin Densitom"},{"key":"6708_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","volume":"22","author":"CR Shuhart","year":"2019","unstructured":"Shuhart CR, Yeap SS, Anderson PA et al (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom 22:453\u2013471","journal-title":"J Clin Densitom"},{"key":"6708_CR16","doi-asserted-by":"crossref","unstructured":"Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142020 update. Endocr Pract 26(Suppl 1):1\u201346","DOI":"10.4158\/GL-2020-0524SUPPL"},{"key":"6708_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12891-016-0886-1","volume":"17","author":"S Amnuaywattakorn","year":"2016","unstructured":"Amnuaywattakorn S, Sritara C, Utamakul C et al (2016) Simulated increased soft tissue thickness artefactually decreases trabecular bone score: a phantom study. BMC Musculoskelet Disord 17:17","journal-title":"BMC Musculoskelet Disord"},{"key":"6708_CR18","doi-asserted-by":"crossref","unstructured":"Shevroja E, Aubry-Rozier B, Hans G, Gonzalez- Rodriguez E, Stoll D, Lamy O, Hans D (2019) Clinical performance of the updated trabecular bone score (TBS) algorithm, which accounts for the soft tissue thickness: the OsteoLaus study. J Bone Miner Res 34:2229\u20132237","DOI":"10.1002\/jbmr.3851"},{"key":"6708_CR19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.292.4.490","volume":"292","author":"LC Hofbauer","year":"2004","unstructured":"Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases. JAMA 292:490\u2013495","journal-title":"JAMA"},{"key":"6708_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"6708_CR21","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA 95:3597\u20133602","journal-title":"Proc Natl Acad Sci USA"},{"key":"6708_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","volume":"157","author":"DL Lacey","year":"2000","unstructured":"Lacey DL, Tan HL, Lu J, Kaufman S, Van G, Qiu W, Rattan A et al (2000) Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol 157:435\u2013448","journal-title":"Am J Pathol"},{"key":"6708_CR23","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1210\/endo.141.9.7634","volume":"141","author":"N Udagawa","year":"2000","unstructured":"Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y et al (2000) Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478\u20133484","journal-title":"Endocrinology"},{"key":"6708_CR24","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"6708_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jocd.2012.02.006","volume":"16","author":"MA Bolognese","year":"2013","unstructured":"Bolognese MA, Teglbj\u00e6rg CS, Zanchetta JR et al (2013) Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the FREEDOM study. J Clin Densitom 16:147\u2013153","journal-title":"J Clin Densitom"},{"key":"6708_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5:513\u2013523","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6708_CR27","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1210\/jc.2019-00271","volume":"104","author":"S Ferrari","year":"2019","unstructured":"Ferrari S, Butler PW, Kendler DL, Miller PD, Roux C, Wang AT, Huang S, Wagman RB, Lewiecki EM (2019) Further nonvertebral fracture reduction beyond 3 years for up to 10 years of denosumab treatment. J Clin Endocrinol Metab 104:3450\u20133461","journal-title":"J Clin Endocrinol Metab"},{"key":"6708_CR28","doi-asserted-by":"crossref","unstructured":"Hans D, Shevroja E, McDermott M et al (2022) Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post-hoc analysis. Osteoporos Int 33:2517\u20132525","DOI":"10.1007\/s00198-022-06549-x"},{"key":"6708_CR29","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"key":"6708_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H (2018) User\u2019s guide to correlation coefficients. Turk J Emerg Med 18:91\u201393","journal-title":"Turk J Emerg Med"},{"key":"6708_CR31","first-page":"e11794","volume":"12","author":"A Rovetta","year":"2020","unstructured":"Rovetta A (2020) Raiders of the lost correlation: a guide on using Pearson and Spearman coefficients to detect hidden correlations in medical sciences. Cureus 12:e11794","journal-title":"Cureus"},{"key":"6708_CR32","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s00198-017-4140-y","volume":"28","author":"MR McClung","year":"2017","unstructured":"McClung MR, Lippuner K, Brandi ML, Zanchetta JR, Bone HG, Chapurlat R, Hans D, Wang A, Zapalowski C, Libanati C (2017) Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis. Osteoporos Int 28:2967\u20132973","journal-title":"Osteoporos Int"},{"key":"6708_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bone.2014.12.062","volume":"75","author":"S Di Gregorio","year":"2015","unstructured":"Di Gregorio S, Del Rio L, Rodriguez-Tolra J, Bonel E, Garc\u00eda M, Winzenrieth R (2015) Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS). Bone 75:138\u2013143","journal-title":"Bone"},{"key":"6708_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.11005\/jbm.2021.28.4.317","volume":"28","author":"C Jeong","year":"2021","unstructured":"Jeong C, Kim J, Lim Y et al (2021) Effect of romosozumab on trabecular bone score compared to anti-resorptive agents in postmenopausal women with osteoporosis. J Bone Metab 28:317\u2013323","journal-title":"J Bone Metab"},{"key":"6708_CR35","doi-asserted-by":"publisher","first-page":"116187","DOI":"10.1016\/j.bone.2021.116187","volume":"154","author":"YJ Hu","year":"2022","unstructured":"Hu YJ, Chines A, Shi Y et al (2022) The effect of denosumab and alendronate on trabecular plate and rod microstructure at the distal tibia and radius: a post-hoc HR-pQCT study. Bone 154:116187","journal-title":"Bone"},{"key":"6708_CR36","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/jbmr.4006","volume":"35","author":"DW Dempster","year":"2020","unstructured":"Dempster DW, Chines A, Bostrom MP et al (2020) Modeling-based bone formation in the human femoral neck in subjects treated with denosumab. J Bone Miner Res 35:1282\u20131288","journal-title":"J Bone Miner Res"},{"key":"6708_CR37","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00198-013-2316-7","volume":"24","author":"JP Roux","year":"2013","unstructured":"Roux JP, Wegrzyn J, Boutroy S et al (2013) The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: an ex vivo study. Osteoporos Int 24:2455\u20132460","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06708-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06708-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06708-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T10:07:03Z","timestamp":1684750023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06708-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6708"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06708-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clarification","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Graphical Abstract was replaced with high resolution file.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the principles of the Declaration of Helsinki. Institutional review boards and ethics committees approved the protocol and consent process. All procedures performed in studies involving humans were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Didier Hans is the co-owner of the TBS patent and has corresponding ownership shares and position at Medimaps group. Enisa Shevroja has no conflict of interest. Michael McClung received honorarium and consulting fees from Amgen. Michele McDermott is an employee and stockholder of Amgen. Shuang Huang is an employee and stockholder of Amgen. Min Kim is an employee and stockholder of Amgen.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}